Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Nutrients ; 9(12)2017 Dec 19.
Artigo em Inglês | MEDLINE | ID: mdl-29257101

RESUMO

In an experimental model of low-level and moderate environmental human exposure to cadmium (Cd), it was investigated whether the consumption of a polyphenol-rich Aronia melanocarpa L. berries (chokeberries) extract (AE) may influence the body status of zinc (Zn) and copper (Cu). The bioelements' apparent absorption, body retention, serum and tissue concentrations, total pool in internal organs, excretion, and the degree of binding to metallothionein were evaluated in female rats administered 0.1% aqueous AE or/and Cd in their diet (1 and 5 mg/kg) for 3-24 months. The consumption of AE alone had no influence on the body status of Zn and Cu. The extract administration at both levels of Cd treatment significantly (completely or partially) protected against most of the changes in the metabolism of Zn and Cu caused by this xenobiotic; however, it increased or decreased some of the Cd-unchanged indices of their body status. Based on the findings, it seems that rational amounts of chokeberry products may be included in the daily diet without the risk of destroying Zn and Cu metabolisms; however, their potential prophylactic use under exposure to Cd needs further study to exclude any unfavourable impact of these essential elements on the metabolism.


Assuntos
Cádmio/toxicidade , Cobre/urina , Photinia/química , Extratos Vegetais/urina , Polifenóis/urina , Zinco/urina , Animais , Disponibilidade Biológica , Cobre/farmacocinética , Duodeno/efeitos dos fármacos , Duodeno/metabolismo , Fezes/química , Feminino , Frutas/química , Rim/efeitos dos fármacos , Rim/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Extratos Vegetais/farmacocinética , Polifenóis/farmacocinética , Ratos , Ratos Wistar , Distribuição Tecidual , Zinco/farmacocinética
2.
Nutrients ; 9(6)2017 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-28587093

RESUMO

The hypothesis that the consumption of Aronia melanocarpa berries (chokeberries) extract, recently reported by us to improve bone metabolism in female rats at low-level and moderate chronic exposure to cadmium (1 and 5 mg Cd/kg diet for up to 24 months), may increase the bone resistance to fracture was investigated. Biomechanical properties of the neck (bending test with vertical head loading) and diaphysis (three-point bending test) of the femur of rats administered 0.1% aqueous chokeberry extract (65.74% of polyphenols) or/and Cd in the diet (1 and 5 mg Cd/kg) for 3, 10, 17, and 24 months were evaluated. Moreover, procollagen I was assayed in the bone tissue. The low-level and moderate exposure to Cd decreased the procollagen I concentration in the bone tissue and weakened the biomechanical properties of the femoral neck and diaphysis. Chokeberry extract administration under the exposure to Cd improved the bone collagen biosynthesis and femur biomechanical properties. The results allow for the conclusion that the consumption of chokeberry products under exposure to Cd may improve the bone biomechanical properties and protect from fracture. This study provides support for Aronia melanocarpa berries being a promising natural agent for skeletal protection under low-level and moderate chronic exposure to Cd.


Assuntos
Densidade Óssea/efeitos dos fármacos , Cádmio/toxicidade , Fêmur/efeitos dos fármacos , Photinia , Extratos Vegetais/farmacologia , Animais , Fenômenos Biomecânicos , Feminino , Fêmur/patologia , Frutas/fisiologia , Humanos , Extratos Vegetais/química , Ratos , Ratos Wistar
3.
Planta Med ; 82(7): 621-31, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-27096624

RESUMO

Recently, we demonstrated in a rat model that consumption of a polyphenol-rich extract obtained from the berries of Aronia melanocarpa could protect from cadmium-induced disorders in bone turnover and changes in bone mineral status. The aim of this study was to investigate whether the osteoprotective effect of this extract is mediated by the oxidative defense system. Enzymatic and nonenzymatic antioxidants, total antioxidative and oxidative status, hydrogen peroxide, and markers of oxidative protein, lipid, and DNA damage were determined in bone tissue at the distal femoral epiphysis of female Wistar rats receiving 0.1 % aqueous A. melanocarpa extract (prepared from the lyophilized commercial extract containing 65.74 % of polyphenols) as the only drinking fluid and/or cadmium in the diet (1 and 5 mg/kg) for 3, 10, 17, and 24 months. The total oxidative and antioxidative status of the serum was also evaluated. The administration of A. melanocarpa extract provided significant protection from cadmium-induced oxidative stress in the bone and serum, and from lipid peroxidation and oxidative damage to the protein and DNA in the bone tissue. Numerous correlations were noted between indices of the oxidative/antioxidative bone status and markers of bone metabolism previously assayed in the animals receiving A. melanocarpa extract. The results allow the conclusion that the ability of A. melanocarpa extract to mediate the oxidative defense system and prevent oxidative modifications of protein, lipid, and DNA in the bone tissue plays an important role in its osteoprotective action under exposure to cadmium. The findings provide further evidence supporting our suggestion that chokeberry may be a promising natural agent for protection against the toxic action of cadmium in women chronically exposed to this metal.


Assuntos
Antioxidantes/farmacologia , Osso e Ossos/efeitos dos fármacos , Cádmio/toxicidade , Photinia/química , Extratos Vegetais/farmacologia , Polifenóis/farmacologia , Animais , Antioxidantes/isolamento & purificação , Dano ao DNA/efeitos dos fármacos , Feminino , Fêmur , Estresse Oxidativo/efeitos dos fármacos , Polifenóis/isolamento & purificação , Ratos , Ratos Wistar , Tíbia
4.
J Trace Elem Med Biol ; 26(1): 46-52, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22100499

RESUMO

It was investigated whether the ability of zinc (Zn) to prevent cadmium (Cd)-induced lipid peroxidation may be connected with its impact on glutathione peroxidase (GPx) activity and selenium (Se) concentration. GPx and Se were determined in the serum, liver and kidney of the rats that received Cd (5 or 50 mg/L) or/and Zn (30 mg/L) in drinking water for 6 months in whose the protective Zn impact was noted (Rogalska J, Brzóska MM, Roszczenko A, Moniuszko-Jakoniuk J. Enhanced zinc consumption prevents cadmium-induced alterations in lipid metabolism in male rats. Chem Biol Interact 2009;177:142-52). Moreover, dependences between these parameters, and indices of lipid peroxidation (F(2)-isoprostane, lipid peroxides, oxidized low density lipoprotein cholesterol) as well as concentrations of Cd and Zn were estimated. The supplementation with Zn during the exposure to 5 mg Cd/L entirely antagonized the Cd-induced increase in GPx activity and Se concentration in the liver and kidney, but not in the serum. Zn administration during the treatment with 50 mg Cd/L totally or partially prevented from the Cd-caused decrease in GPx activity and Se concentration in the serum, liver and kidney. At the higher level of Cd exposure, GPx activity in the serum and tissues positively correlated with Se concentration. Moreover, numerous correlations were noted between GPx and/or Se and the indices of lipid peroxidation. The results indicate that the protective impact of Zn against the Cd-induced lipid peroxidation during the relatively high exposure might be connected with its beneficial influence on Se concentration and GPx activity in the serum and tissues, whereas this bioelement influence at the moderate exposure seems to be independent of GPx and Se.


Assuntos
Cádmio/toxicidade , Glutationa Peroxidase/metabolismo , Rim/metabolismo , Fígado/metabolismo , Selênio/metabolismo , Zinco/administração & dosagem , Animais , Suplementos Nutricionais , Rim/efeitos dos fármacos , Peroxidação de Lipídeos , Fígado/efeitos dos fármacos , Masculino , Estresse Oxidativo , Ratos , Ratos Wistar , Selênio/sangue , Zinco/metabolismo
5.
Exp Toxicol Pathol ; 63(5): 491-8, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20385473

RESUMO

The aim of this study was to evaluate whether zinc (Zn) supplementation can protect from an enhanced risk of femoral neck fracture due to chronic exposure to cadmium (Cd). For this purpose, biomechanical properties of the neck and bone mineral density (BMD) at the proximal femur of rats receiving Cd (5 or 50mg/l) or/and Zn (30 or 60 mg/l) in drinking water for 6 and 12 months were evaluated. The exposure to 5 and 50mg Cd/l decreased the proximal femur BMD and affected biomechanical properties of the femoral neck. In the rats treated with 5mg Cd/l, weakening of the femoral neck strength was observed after 12 months, whereas at higher exposure--already after 6 months. The supplementation with 30 and 60 mg Zn/l, enhancing its daily intake by 68% and 138%, respectively, compared to the standard diet, had beneficial influence on the femoral neck biomechanical properties during the exposure to Cd, but it had no impact on the proximal femur BMD. Zn administration during the 12-month exposure to 5mg Cd/l totally prevented the weakening of the neck. Zn supplementation during the 6-month treatment with 50mg Cd/l entirely prevented the Cd-induced decrease in the neck fracture strength; however, at the longer exposure to Cd the protective effect of Zn was only partial. The beneficial Zn influence was independent on its dose. The results allow the conclusion that an increase in the daily intake of Zn during moderate and relatively high exposures to Cd can reduce femoral neck susceptibility to fracture. Based on the findings, it seems that enhanced Zn consumption in subjects chronically exposed to Cd may, at least partly, protect from the enhanced risk of femoral neck fracture.


Assuntos
Cloreto de Cádmio/toxicidade , Suplementos Nutricionais , Poluentes Ambientais/toxicidade , Fraturas do Colo Femoral/prevenção & controle , Colo do Fêmur/efeitos dos fármacos , Zinco/uso terapêutico , Animais , Densidade Óssea/efeitos dos fármacos , Cloreto de Cádmio/sangue , Cloreto de Cádmio/farmacocinética , Poluentes Ambientais/farmacocinética , Fraturas do Colo Femoral/metabolismo , Colo do Fêmur/diagnóstico por imagem , Colo do Fêmur/metabolismo , Masculino , Radiografia , Ratos , Ratos Wistar , Risco , Fatores de Tempo , Zinco/administração & dosagem , Zinco/farmacologia
6.
Chem Biol Interact ; 171(3): 312-24, 2008 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-18164699

RESUMO

The present study was aimed at estimate, based on the rat model of human moderate and relatively high chronic exposure to cadmium (Cd), whether zinc (Zn) supplementation may prevent Cd-induced weakening in the bone biomechanical properties. For this purpose, male Wistar rats were administered Cd (5 or 50 mg/l) or/and Zn (30 or 60 mg/l) in drinking water for 6 and 12 months. Bone mineral density (BMD) and biomechanical properties (yield load, ultimate load, post-yield load, displacement at yield and at ultimate, stiffness, work to fracture, yield stress, ultimate stress and Young modulus of elasticity) of the femoral distal end and femoral diaphysis were examined. Biomechanical properties of the distal femur were estimated in a compression test, whereas those of the femoral diaphysis -- in a three-point bending test. Exposure to Cd, in a dose and duration dependent manner, decreased the BMD and weakened the biomechanical properties of the femur at its distal end and diaphysis. Zn supplementation during Cd exposure partly, but importantly, prevented the weakening in the bone biomechanical properties. The favorable Zn influence seemed to result from an independent action of this bioelement and its interaction with Cd. However, Zn supply at the exposure to Cd had no statistically significant influence on the BMD at the distal end and diaphysis of the femur. The results of the present paper suggest that Zn supplementation during exposure to Cd may have a protective influence on the bone tissue biomechanical properties, and in this way it can, at least partly, decrease the risk of bone fractures. The findings seem to indicate that enhanced dietary Zn intake may be beneficial for the skeleton in subjects chronically exposed to Cd.


Assuntos
Cádmio/toxicidade , Diáfises/efeitos dos fármacos , Suplementos Nutricionais , Fêmur/efeitos dos fármacos , Zinco/administração & dosagem , Absorciometria de Fóton , Administração Oral , Animais , Fenômenos Biomecânicos , Densidade Óssea/efeitos dos fármacos , Cádmio/antagonistas & inibidores , Diáfises/diagnóstico por imagem , Diáfises/metabolismo , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Fêmur/diagnóstico por imagem , Fêmur/metabolismo , Masculino , Ratos , Ratos Wistar
7.
Toxicology ; 237(1-3): 89-103, 2007 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-17560002

RESUMO

The aim of the present study is to investigate, based on the rat model of moderate and relatively high human exposure to cadmium (Cd), whether zinc (Zn) supplementation may prevent Cd-induced disorders in bone metabolism. For this purpose, male Wistar rats received Cd (5 and 50mg/l) or/and Zn (30 and 60mg/l) in drinking water for 6 and 12 months. Bone densitometry and biochemical markers of bone turnover were used to assess the effects of Cd or/and Zn. Bone mineral content (BMC) and density (BMD) were measured in the femur. Serum osteocalcin (OC) and alkaline phosphatase in trabecular (bT-ALP) and cortical (bC-ALP) bone were determined as bone formation markers, and carboxy-terminal cross-linking telopeptides of type I collagen (CTX) in serum were measured as bone resorption marker. Serum concentration of calcium (Ca) and its renal handling, as well as Zn and Cd concentrations in the serum/blood, urine and femur were evaluated as well. The exposure to 5 and 50mg Cd/l (0.340+/-0.026 and 2.498+/-0.093mg Cd/kg body wt/24h, respectively), in a dose and duration dependent manner, affected bone turnover (inhibited bone formation and stimulated its resorption) and disturbed bone mineralization (decreased BMC, BMD and Zn concentration). Zn supply at the concentration of 30 and 60mg/l (1.904+/-0.123 and 3.699+/-0.213mg/kg body wt/24h, respectively) during Cd exposure influenced the Cd-induced disorders in bone metabolism. Zn administration to the Cd-exposed rats enhanced the bone ALP activity and prevented Cd-induced bone resorption, but had no statistically significant effect on BMC and BMD; however, mean values of the densitometric parameters in the rats receiving both Cd and Zn were higher than in those treated with Cd alone. Moreover, Zn supplementation at both levels of Cd exposure was found to prevent Cd accumulation in the femur and the Cd-induced decrease in bone Zn concentration. The results of the present study allow the conclusion that Zn supplementation during Cd exposure may partly protect from disorders in bone metabolism. The influence of Zn may be accompanied by its ability to prevent Cd-induced Zn deficiency and to decrease Cd accumulation in bone tissue. The findings seem to indicate that enhanced dietary intake of Zn in subjects chronically exposed to moderate and relatively high Cd levels may have a protective influence on the skeleton.


Assuntos
Reabsorção Óssea , Osso e Ossos/metabolismo , Cloreto de Cádmio/toxicidade , Cloretos , Compostos de Zinco , Absorciometria de Fóton , Animais , Peso Corporal/efeitos dos fármacos , Densidade Óssea/efeitos dos fármacos , Reabsorção Óssea/induzido quimicamente , Reabsorção Óssea/metabolismo , Reabsorção Óssea/prevenção & controle , Osso e Ossos/efeitos dos fármacos , Cloreto de Cádmio/farmacocinética , Cálcio/sangue , Cloretos/administração & dosagem , Cloretos/farmacocinética , Cloretos/farmacologia , Cloretos/uso terapêutico , Colágeno Tipo I/sangue , Interações Medicamentosas , Fêmur/efeitos dos fármacos , Fêmur/metabolismo , Masculino , Osteocalcina/sangue , Peptídeos/sangue , Ratos , Ratos Wistar , Compostos de Zinco/administração & dosagem , Compostos de Zinco/farmacocinética , Compostos de Zinco/farmacologia , Compostos de Zinco/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA